Filing Details
- Accession Number:
- 0000899243-19-026636
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-05 06:08:10
- Reporting Period:
- 2019-11-04
- Accepted Time:
- 2019-11-05 06:08:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1720725 | Oyster Point Pharma Inc. | OYST | Biological Products, (No Disgnostic Substances) (2836) | 811030955 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1791187 | Daniel Lochner | C/O Oyster Point Pharma, Inc. 202 Carnegie Center, Suite 109 Princeton NJ 08540 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2019-11-04 | 6,300 | $16.00 | 6,300 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
